ICD-10-CM · General

M33.13

M33.13 identifies adult-onset dermatomyositis — a systemic inflammatory disorder classified under 'Other dermatomyositis' — in which the characteristic cutaneous manifestations (heliotrope rash, Gottron's papules, mechanic's hands) are present but documented muscle inflammation or clinical myopathy is absent at the time of coding.

Verified May 8, 2026 · 6 sources ↓

Status
Billable
Chapter
13
Related CPT
7
Region
General
Drawn from CDCICD10DataAAPCOutsourcestrategiesCdek

Documentation tips

What should appear in the chart to support M33.13.

Source · Editorial brief grounded in 6 cited references ↓

  • Provider must explicitly state 'without myopathy' or 'amyopathic' — absence of a myopathy code is not sufficient; the note must affirmatively exclude muscle involvement to justify M33.13 over M33.10.
  • Document the specific cutaneous findings that support the diagnosis: heliotrope rash, Gottron's papules or Gottron's sign, periungual erythema, or mechanic's hands.
  • Record muscle enzyme levels (CK, aldolase, LDH) and EMG or MRI findings that substantiate the absence of myopathy — this is your audit defense for the 'without' designation.
  • Note whether the patient is adult-onset; if under 18, the correct code is M33.03, not M33.13.
  • If interstitial lung disease or another organ manifestation is documented, specify it — that may shift the correct code from M33.13 to M33.11 or M33.19.
  • Document any associated malignancy separately and sequence it according to the reason for the encounter, since dermatomyositis has a recognized paraneoplastic association.

Related CPT procedures

Procedure codes commonly billed with M33.13. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M33.13 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Defaulting to M33.10 (organ involvement unspecified) when the provider has documented absent myopathy — M33.13 is the correct, more specific code and should be used whenever the record affirmatively excludes muscle involvement.
  • Using M33.13 for a pediatric patient: juvenile dermatomyositis without myopathy maps to M33.03, not M33.13.
  • Assigning M33.13 when respiratory involvement is also documented — the co-existence of ILD or respiratory manifestations should redirect to M33.11 (with respiratory involvement) or M33.19 (with other organ involvement).
  • Confusing M33.13 with polymyositis codes (M33.2x) — dermatomyositis and polymyositis are distinct clinical entities with separate code blocks; the presence of skin findings is the distinguishing clinical feature pointing to M33.13.
  • Omitting secondary codes for organ manifestations such as pulmonary fibrosis (J84.10) or associated malignancy — M33.13 alone does not capture the full clinical picture when complications are present.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

M33.13 applies to adult patients with dermatomyositis (including amyopathic dermatomyositis and dermatomyositis sine myositis) where the provider has explicitly documented that no myopathy is present. This is the 'without myopathy' fifth-character variant under parent code M33.1 (Other dermatomyositis). The parallel juvenile code is M33.03; do not use M33.13 for patients under 18.

The critical branch point within M33.1 is muscle involvement: M33.12 = with myopathy, M33.13 = without myopathy, M33.10 = organ involvement unspecified (use only when the record is silent on muscle status), M33.11 = with respiratory involvement, M33.19 = with other organ involvement. If the record documents both absent myopathy and, say, interstitial lung disease, the respiratory involvement code M33.11 takes precedence over M33.13 — code to the most specific organ manifestation documented.

Additional codes may be required for associated manifestations. Common companions include J84.10 (pulmonary fibrosis, unspecified) when interstitial lung disease is present, or relevant skin-finding codes when the dermatologic picture needs independent tracking. Dermatomyositis carries a known paraneoplastic association; if a concurrent malignancy is documented, code it separately and sequence according to the reason for the encounter.

Inclusion & exclusion notes

Per the official ICD-10-CM Tabular List.

Source · CDC ICD-10-CM Official Tabular List · 2026

Includes

  • Dermatomyositis NOS

Sibling codes

Other billable codes under M33.1 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01What is the difference between M33.13 and M33.10?
M33.10 is used when the record is silent on whether myopathy is present; M33.13 requires the provider to affirmatively document that myopathy is absent. Always use M33.13 when the note explicitly states 'without myopathy' or 'amyopathic' — it is the more specific code and payers expect it when clinical evidence supports it.
02Can M33.13 be used for amyopathic dermatomyositis?
Yes. The ICD-10-CM Alphabetic Index routes both 'amyopathic dermatomyositis' and 'dermatomyositis without myopathy' to M33.13. These are clinically synonymous presentations for coding purposes under the 2026 code set.
03Does M33.13 require a 7th character?
No. M33.13 is a 5-character code in the M-code chapter (musculoskeletal and connective tissue). The 7th-character extension convention applies to injury codes (S-codes and T-codes), not to M-codes like M33.13.
04When should I use M33.12 instead of M33.13?
Use M33.12 (Other dermatomyositis with myopathy) when the provider documents muscle weakness, elevated muscle enzymes, abnormal EMG, or muscle biopsy findings consistent with inflammatory myopathy alongside the skin findings. M33.13 is the correct choice only when the provider affirmatively excludes muscle involvement.
05Should I add a separate code for interstitial lung disease if a patient with M33.13 also has ILD?
If ILD is the documented organ manifestation, reconsider whether M33.11 (with respiratory involvement) is the more accurate primary code rather than M33.13. If you retain M33.13, add a secondary code such as J84.10 to capture the pulmonary complication — but review the clinical record carefully to determine which 5th-character variant best reflects the principal manifestation.
06Is M33.13 appropriate if a malignancy is also present?
Yes, you may code M33.13 alongside a malignancy code, but sequence based on the reason for the encounter. Dermatomyositis has a recognized paraneoplastic association; when a concurrent malignancy is documented, the malignancy typically requires its own code and sequencing is encounter-driven, not automatically secondary.
07What is the ICD-9-CM crosswalk for M33.13?
M33.13 crosswalks from ICD-9-CM code 710.3 (Dermatomyositis). The ICD-10-CM expansion introduced the myopathy/without-myopathy distinction at the fifth-character level, so the old 710.3 maps to multiple M33.1x codes depending on muscle involvement documentation.

Mira AI Scribe

Mira AI Scribe captures the provider's explicit statement that myopathy is absent, documents the specific skin findings (heliotrope rash, Gottron's papules, mechanic's hands), records muscle enzyme results and any EMG/MRI data supporting no muscle inflammation, and notes the patient's age as adult-onset. That documentation prevents downcoding to the unspecified M33.10 and flags whether co-existing organ involvement (e.g., ILD) should redirect coding to M33.11 or M33.19 instead.

See how Mira captures M33.13 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free